Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

The status of KRAS mutations in patients with non-small cell lung cancers from mainland China.

Oncology reports - 1 Nov 2009

Li Mei, Liu Lina, Liu Zhimin, Yue Shichang, Zhou Luming, Zhang Qiuping, Cheng Shihua, Li Rachel W, Smith Paul N, Lu Shen

Abstract excerpt

KRAS mutation is closely associated to carcinogenesis and prognosis of non-small cell lung cancer (NSCLC). Detection of KRAS mutation can also be used to select NSCLC patients for drug targeting with EGFR tyrosine kinase inhibitors. Data regarding the status of KRAS mutation in mainland China, wh...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Carcinoma, Non-Small-Cell Lung
Share to China
Share to Lung

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Lung Neoplasms

Share to Proto-Oncogene Proteins

Share to Proto-Oncogene Proteins p21(ras)

Share to ras Proteins

Share to Tumor Cells, Cultured

Source

Identifiers

PMID: 19787214
DOI: 10.3892/or_00000529

Genes

KRAS
EGFR

Variants

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026. Prepared record publication-19787214-2026-09-02.2. Manifest publication-graph-cohort-2026-09-02.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

The status of KRAS mutations in patients with non-small cell lung cancers from mainland China.PMID 19787214Read ↗

Impact of KRAS mutation on response and outcome of patients with stage III non-squamous non-small cell lung cancer.Semantic proximity Read ↗

Mutation detection of KRAS by high-resolution melting analysis in Chinese with gastric cancer.Semantic proximity Read ↗

Diagnostic accuracy of high resolution melting analysis for detection of KRAS mutations: a systematic review and meta-analysis.Semantic proximity Read ↗

The Prevalence and Concurrent Pathogenic Mutations of KRASG12C in Northeast Chinese Non-small-cell Lung Cancer PatientsSemantic proximity Read ↗

Melting curve analysis for mutations of EGFR and KRAS.Semantic proximity Read ↗

High resolution melting analysis for the rapid and sensitive detection of mutations in clinical samples: KRAS codon 12 and 13 mutations in non-small cell lung cancer.Semantic proximity Read ↗

Detection of KRAS mutations in colorectal cancer by high-resolution melting analysis.Semantic proximity Read ↗

Detection of EGFR and KRAS mutations on trans-thoracic needle aspiration of lung nodules by high resolution melting analysis.Semantic proximity Read ↗

The impact of cigarette smoking on the frequency of and qualitative differences in KRAS mutations in Korean patients with lung adenocarcinoma.Semantic proximity Read ↗

A comparison of Direct sequencing, Pyrosequencing, High resolution melting analysis, TheraScreen DxS, and the K-ras StripAssay for detecting KRAS mutations in non small cell lung carcinomas.Semantic proximity Read ↗

Evaluation of the simultaneous effects of KRAS G12V and LCS6 alterations on the behavior of head and neck squamous cell carcinoma.Semantic proximity Read ↗

Comparison of Sanger sequencing, pyrosequencing, and melting curve analysis for the detection of KRAS mutations: diagnostic and clinical implications.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.